Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the "return on patient engagement initiatives" in medicines research and development: A literature review.
Vat LE, Finlay T, Jan Schuitmaker-Warnaar T, Fahy N, Robinson P, Boudes M, Diaz A, Ferrer E, Hivert V, Purman G, Kürzinger ML, Kroes RA, Hey C, Broerse JEW. Vat LE, et al. Among authors: kurzinger ml. Health Expect. 2020 Feb;23(1):5-18. doi: 10.1111/hex.12951. Epub 2019 Sep 6. Health Expect. 2020. PMID: 31489988 Free PMC article. Review.
Comparison of text processing methods in social media-based signal detection.
Gavrielov-Yusim N, Kürzinger ML, Nishikawa C, Pan C, Pouget J, Epstein LB, Golant Y, Tcherny-Lessenot S, Lin S, Hamelin B, Juhaeri J. Gavrielov-Yusim N, et al. Among authors: kurzinger ml. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1309-1317. doi: 10.1002/pds.4857. Epub 2019 Aug 7. Pharmacoepidemiol Drug Saf. 2019. PMID: 31392844
A pilot study on the incidence of severe photosensitivity reactions leading to hospitalization linked to topical ketoprofen and other medications in selected European regions.
Cazzaniga S, Naldi L, Lecchi S, Kürzinger ML, Auclert L, Gori M, Chosidow O, Hercogova J. Cazzaniga S, et al. Among authors: kurzinger ml. Pharmacol Res Perspect. 2016 Apr 27;4(3):e00225. doi: 10.1002/prp2.225. eCollection 2016 Jun. Pharmacol Res Perspect. 2016. PMID: 27433339 Free PMC article.
Structured benefit-risk assessment for enoxaparin, in the context of its label extension, for the extended treatment of deep vein thrombosis and pulmonary embolism, and prevention of its recurrence in patients with active cancer.
Kürzinger ML, El-Haddad C, Gouin-Soboleva T, Fazekas Z, Granados D, Benito-Garcia E, Djoudi Y. Kürzinger ML, et al. Pharmacoepidemiol Drug Saf. 2024 May;33(5):e5795. doi: 10.1002/pds.5795. Pharmacoepidemiol Drug Saf. 2024. PMID: 38680090
14 results